[ad_1]
rehe United States is campaigning to immunize the population after the first approval of a coronavirus vaccine. The pharmaceutical agency FDA had granted the drug from Mainz biotech company Biontech and its US partner Pfizer an emergency approval on Friday night. Now unprecedented mass vaccines are going to be launched, with which the United States, which has been the worst affected by the pandemic in the world, wants to change things.
President-elect Donald Trump promised his compatriots the first vaccines this weekend after approval. “The first vaccine will be administered in less than 24 hours,” Trump announced in a video posted on Twitter. Your government has already started shipping the vaccine. However, Gustave Perna, head of logistics for “Operation Warp Speed,” the White House vaccination project, said on Saturday that vaccination would not take place until Monday. By the end of the month, 2.9 million units of vaccine will be administered. Nursing staff and the elderly in particular should be among the first beneficiaries.
The country has almost 300,000 dead
Logistics companies like United Parcel Service and Fedex say they are ready to ship millions of vaccine units. These transmissions have the highest priority. Transport companies must meet special requirements, because the vaccine must be stored at minus 70 degrees. Security forces must also monitor deliveries. In New York, Mayor Bill di Blasio emphasized: “This is unprecedented because it is not just a logistics problem. It’s about gaining the public’s trust, it’s about justice. “
The vaccine cleared the critical hurdle to approval Thursday after the FDA’s independent Vaccine Advisory Committee voted overwhelmingly in favor of approval. It is the first Covid-19 vaccine available in the United States. The European Medicines Agency (EMA) intends to complete the evaluation of the company’s application for a conditional marketing authorization by December 29 at the latest.
The UK became the first country in the world to grant an emergency vaccine permit on December 2 and began mass vaccinations just under a week later. The preparation then received the green light from Canada, the Kingdom of Bahrain, Saudi Arabia and Mexico. Currently, the vaccine is considered one of the most promising means of containing the coronavirus pandemic. More than 1.5 million people around the world have died from or with the virus.
The United States is the country most affected by the pandemic in the world, with almost 300,000 deaths. On Friday, the US epidemic agency CDC reported 200,000 new infections. This increased the number of those who tested positive to almost 15.5 million. The John Hopkins Health Center cautioned against excessive expectations. Starting vaccinations is just one step among many, said researcher Amesh Adalja. “There will be many more people infected, many will be hospitalized and many will die before vaccines have a noticeable effect on the spread (of the disease).”
In early November, Biontech and Pfizer were the first companies in the world to announce positive results of the relevant study for approval with a corona vaccine. According to a final analysis, the vaccine showed 95 percent protection against Covid-19. After the vaccine from Biontech and Pfizer, the one from American biotech Moderna could be the next to receive approval in the United States. On Dec. 17, the FDA’s Vaccine Advisory Committee plans to evaluate this vaccine, which, according to study results, is 94 percent effective.
The United States has signed a contract with Biontech and Pfizer to supply 100 million doses of vaccines valued at around $ 1.95 billion, with the option to purchase an additional 500 million doses. The European Union has secured up to 300 million doses, the federal government expects up to 100 million doses of vaccines for Germany. The two partners want to produce up to 50 million doses of vaccines this year and up to 1.3 billion next year.
